Lupin receives US FDA approval for tobramycin inhalation solution
The product is Lupin's first generic approval in the inhalation space
 "Lupin receives US FDA for electrolyte replenisher")
premium
Lupin Limited has received final approval for its tobramycin inhalation solution (300 mg/5 ml) from the US Food and Drug Administration (FDA). The approved product is the generic version of Novartis Pharmaceuticals Corporation’s Tobi.